Orexo Names Key Members for 2025 Annual General Meeting
Orexo Announces Nomination Committee for Upcoming AGM
UPPSALA, Sweden – Orexo has officially appointed the members of its Nomination Committee ahead of the Annual General Meeting (AGM) scheduled for May 2025. This committee plays a vital role in shaping the future leadership and governance of the company.
Members of the Nomination Committee
The Nomination Committee is chaired by Henrik Kjaer Hansen, representing Novo Holdings A/S. Joining him on the committee are Claus Berner Møller from The Danish Labour Market Supplementary Pension, ATP, private investor Stefan Hansson, and James Noble, who serves as the Chairman of the Board of Orexo. This diverse group brings a wealth of experience and insight to the committee.
Key Responsibilities of the Nomination Committee
In preparation for the AGM, the Nomination Committee is tasked with proposing candidates for critical positions within the company. This includes nominations for the Chairman of the meeting, Chairman of the Board, and Board members, as well as recommendations on Board member fees and any remuneration for committee participation. They will also set forth principles for the composition of the committee itself.
Engagement with Shareholders
Orexo encourages shareholders who wish to contribute to the nomination process to submit proposals. They can contact the committee directly via email, ensuring that their voices are heard in shaping the governance of the company.
About Orexo
Orexo AB (publ.) is a prominent Swedish pharmaceutical company with nearly 30 years of expertise in developing advanced pharmaceutical formulations addressing significant medical needs. The company focuses on innovative treatment solutions, particularly for patients grappling with opioid use disorder in the US market. Orexo collaborates with leading partners around the globe to develop and commercialize products aimed at various therapeutic areas.
Financial Performance and Market Presence
In the previous fiscal year, Orexo reported total net sales of SEK 639 million, highlighting its strong market position and continued growth. With a dedicated workforce of 116 employees, Orexo stands listed on Nasdaq Stockholm’s main list and is also available as an American Depository Receipt on OTCQX under the ticker ORXOY in the United States, reflecting its commitment to accessibility and investor engagement.
Frequently Asked Questions
What is Orexo’s main business focus?
Orexo specializes in developing innovative pharmaceuticals, particularly for opioid use disorder and other critical medical needs.
Who leads Orexo’s Nomination Committee?
The committee is chaired by Henrik Kjaer Hansen, appointed by Novo Holdings A/S.
When is Orexo’s Annual General Meeting scheduled?
The AGM is set for May 8, 2025.
How can shareholders participate in the nomination process?
Shareholders can submit proposals via email to the Nomination Committee before the deadline.
Where can I find more information about Orexo?
For more details, visit Orexo’s official website and stay updated on their initiatives and product offerings.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Iceland:OR Issues Base Prospectus for New Bonds
- Top Dividend Stocks to Consider for Income Investors Today
- Top Semiconductor Stocks to Consider for 2025 Investment
- Foresight Technology VCT plc Announces Strategic Share Buyback
- U.S. Economic Outlook: Insights for Sustained Growth
- Wall Street Analysts Adjust Accolade's Price Predictions Before Earnings
- Vodacom Positioned for Growth Amid Industry Trends and Ratings
- Barrick Gold: A Strong Contender for Future Investment Growth
- Exploring High-Performance Momentum Stocks for Investors
- Looking Forward: Stock Market Insights and Future Trends
Recent Articles
- Orexo Nominates Members for Upcoming Annual Meeting
- Central Banks Explore Dynamic Responses in Volatile Landscape
- Market Volatility Amid Rising Global Tensions and Crude Prices
- Bekaert Reports Progress of Recent Liquidity Agreement
- Trevian Asset Management Launches Infrastructure Investment Focus
- Skanska Secures $54M Contract for Houston Healthcare Facility
- Streamline Health Solutions: Navigating Challenges and Opportunities
- Seven & i Plans Strategic Sale of Supermarket Stake Soon
- Taiwan Stock Market Soars: Highlights and Key Players
- HMS Networks AB Forms Nomination Committee for Upcoming AGM
- Octopus Apollo VCT Announces Upcoming Subscription Offer
- ICG Enterprise Trust plc Completes Share Buyback Initiative
- PayPoint plc Engages in Strategic Share Buyback Initiative
- Skanska Partners with McCourt for Major I-95 Project in USD 417M Deal
- Explore the Cultural Wonders of Echizen with a Unique Tour
- Skanska Takes Charge of Major I-95 Renovation Project
- Jyske Bank Successfully Completes Share Repurchase Program
- Recordati Expands Rare Diseases Portfolio with Enjaymo® Acquisition
- Hexagon Purus and Daimler Truck North America Adjust Supply Pact
- Hyundai Mobis Reveals 65 Innovative Mobility Technologies
- Potential Bump Ahead for China's Stock Market Rally
- Sampo plc's Recent Share Buyback Update and Insights
- India's Services Sector Slows, PMI Indices Show Decline
- Arcadis Initiates Share Buyback to Support Employee Incentives
- TGS to Host Q3 2024 Presentation with CEO and CFO Insights
- Alstom Forecasts Exciting Q2 and H1 Results Ahead
- Molecular Partners to Showcase Innovative DARPin Research Ahead
- CareEdge Expands Horizons with Global Sovereign Ratings Launch
- Unwind in Paradise: The Seminyak Beach Resort's Escape
- Macron Engages Wall Street on France's Financial Future
- Decarbonizing Web 3.0: A Green Future with AQGroup and MVGX
- Oil Price Surge: Economic Implications Amidst Global Tensions
- Sirnaomics Secures Major Funding Boost for Business Expansion
- ABL Bio's New Collaboration to Enhance Cancer Treatment
- Market Dynamics: Ethereum, Bitcoin, and XRP in Turmoil
- Bruno Hasulyo: Revolutionizing Stand-Up Paddling in China
- US Job Market Trends: Insights into Growth and Rates
- End of Port Strike: What It Means for Cargo and Economy
- Urgent Notice for DexCom, Inc. Investors: Act Before Deadline
- WM Technology's Investor Rights: What You Need to Know
- Mark Zuckerberg Surges in Wealth, Leaves Bezos Behind
- The Inspirational Journey of Mrs. B: A Legacy of Success
- Investors of WEBTOON Entertainment: Take Action Before Deadline
- Lululemon Investors Notify of Key Deadline – Join the Class Action
- Sanders Applauds Port Workers' Strike Resolution Amid Industry Changes
- OpenAI Boosts Financial Flexibility with $4B Credit Line
- Recent YouTube Account Bans: A Deep Dive into the Issues
- Exploring the Surge in Options Trading for Ferrari Stocks
- Exploring the Latest Market Trends in Cannabis Stocks
- Evaluating United Therapeutics Inc's Stock Dynamics and P/E Ratio